INTERSECT ENT INC (XENT) Forecast, Price Target & Analyst Ratings

NASDAQ:XENT • US46071F1030

Current stock price

28.24
0 (0%)
At close:
28.24
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INTERSECT ENT INC (XENT).

Forecast Snapshot

Consensus Price Target

Price Target
$28.82
+ 2.04% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 4, 2022
Period
Q2 / 2022
EPS Estimate
-$0.33
Revenue Estimate
32.538M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
45.71%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$28.82
Upside
+ 2.04%
From current price of $28.24 to mean target of $28.82, Based on 7 analyst forecasts
Low
$28.53
Median
$28.82
High
$29.66

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for XENT. The average price target is 28.82 null. This implies a price increase of 2.04% is expected in the next year compared to the current price of 28.24.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

XENT Current Analyst RatingXENT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

XENT Historical Analyst RatingsXENT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
45.71%
XENT was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about XENT.
In the previous month the buy percentage consensus was at a similar level.
XENT was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-08-12SVB LeerinkDowngrade Outperform -> Market Perform
2021-08-10BTIGDowngrade Buy -> Neutral
2021-08-09GuggenheimDowngrade Buy -> Neutral
2021-08-09Canaccord GenuityDowngrade Buy -> Hold
2021-06-24SVB LeerinkUpgrade Market Perform -> Outperform
2021-05-11SVB LeerinkMaintains Market Perform
2021-03-10SVB LeerinkMaintains Market Perform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 4, 2022
Period
Q2 / 2022
EPS Estimate
-$0.33
Revenue Estimate
32.538M
Revenue Q2Q
18.97%
EPS Q2Q
33.39%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

XENT is expected to report earnings on 8/4/2022. The consensus EPS estimate for the next earnings is -0.33 null and the consensus revenue estimate is 32.54M null.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2022 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
XENT revenue by date.XENT revenue by date.
109.1M
0.55%		80.6M
-26.12%		106.75M
32.44%		137.817M
29.10%		172.486M
25.16%		202.431M
17.36%		242.327M
19.71%
EBITDA
YoY % growth
XENT ebitda by date.XENT ebitda by date.
-41.5M
-79.50%		-62.63M
-50.92%		-67.87M
-8.37%		N/AN/AN/AN/A
EBIT
YoY % growth
XENT ebit by date.XENT ebit by date.
-45.4M
-81.60%		-67.7M
-49.12%		-72.68M
-7.36%		N/AN/AN/AN/A
Operating Margin
XENT operating margin by date.XENT operating margin by date.
-41.61%-84.00%-68.08%N/AN/AN/AN/A
EPS
YoY % growth
XENT eps by date.XENT eps by date.
-1.37
-80.26%		-2.16
-57.66%		N/A
16.79%		-1.13
37.00%		-1.10
2.52%		-1.30
-17.41%		-1.55
-19.76%

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 22 Q3 / 22 Q4 / 22
EPS
Q2Q % growth		-0.33
33.39%		-0.30
38.38%		-0.18
44.62%
Revenue
Q2Q % growth		32.538M
18.97%		36.164M
48.21%		42.748M
39.38%
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/A

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

XENT Yearly Revenue VS EstimatesXENT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
XENT Yearly EPS VS EstimatesXENT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.5 -1 -1.5 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
8.55%
EPS Next 5 Year
3.25%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
18.84%
Revenue Next 5 Year
19.06%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

INTERSECT ENT INC / XENT Forecast FAQ

What do analysts expect the price target to be for INTERSECT ENT INC (XENT)?

7 analysts have analysed XENT and the average price target is 28.82 null. This implies a price increase of 2.04% is expected in the next year compared to the current price of 28.24.

What is the next earnings date for XENT stock?

INTERSECT ENT INC (XENT) will report earnings on 2022-08-04.

What are the consensus estimates for XENT stock next earnings?

The consensus EPS estimate for the next earnings of INTERSECT ENT INC (XENT) is -0.33 null and the consensus revenue estimate is 32.54M null.

Can you provide the expected long term growth rate for INTERSECT ENT INC stock?

The expected long term growth rate for INTERSECT ENT INC (XENT) is 18.84%.